Menstrual cycle characteristics and history of ovulatory infertility in relation to breast cancer risk in a large cohort of US women

American Journal of Epidemiology
M GarlandW C Willett

Abstract

Menstrual cycle characteristics and ovulatory infertility were evaluated in relation to breast cancer risk among 116,678 women in the Nurses' Health Study II, a prospective cohort study of female registered nurses who were aged 25-42 years and living in 14 US states at enrollment in 1989. During 396,299 person-years of follow-up between return of the baseline questionnaire and June 1993, 251 cases of breast cancer were identified in this cohort. The multivariate relative risk (RR) associated with age at menarche > 13 years compared with age < or = 12 years was 0.66 (95% confidence interval (CI) 0.44-0.99). Short and long menstrual cycle lengths at ages 18-22 years were associated with reduced risk. Compared with menstrual cycle length 26-31 days, the multivariate relative risks (95% CIs) for more extreme cycle lengths were: < 26 days, 0.50 (0.25-0.98); 32-39 days, 0.81 (0.51-1.28); and > 39 days or too irregular for estimation of a usual cycle length, 0.41 (0.18-0.94). The multivariate relative risk associated with a history of ovulatory infertility, compared with no such history, was 0.41 (95% CI 0.18-0.93). These results are consistent with the hypothesis that reduced exposure to ovulatory menstrual cycles provides a protecti...Continue Reading

Citations

Dec 8, 2010·Archives of Pediatrics & Adolescent Medicine·Daphne C HernandezEmily A Doyle
Feb 5, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·A TavaniS Franceschi
May 22, 2003·Best Practice & Research. Clinical Obstetrics & Gynaecology·Alison VennRobert McLachlan
Nov 13, 2004·Psychological Bulletin·Bruce J Ellis
Mar 17, 2010·International Journal of Obesity : Journal of the International Association for the Study of Obesity·L K OlsonS Z Haslam
May 15, 2001·Journal of Internal Medicine·W C Willett
Sep 12, 2003·The New England Journal of Medicine·Frank M Biro
Jun 30, 2011·Journal of Women's Health·Renée Boynton-JarrettRosalind J Wright
Jan 11, 2003·American Journal of Epidemiology·Karen SteindorfJenny Chang-Claude
Dec 23, 2009·American Journal of Epidemiology·Chunyan HeFrank B Hu
Sep 14, 2011·American Journal of Epidemiology·Holly R HarrisKarin B Michels
Feb 22, 2012·American Journal of Epidemiology·Sonya S DasharathyEnrique F Schisterman
Jan 5, 2002·Human Reproduction·F Clavel-Chapelon, UNKNOWN E3N-EPIC group. European Prospective Investigation into Cancer
Aug 13, 1998·Journal of the National Cancer Institute·J F Dorgan
Nov 5, 1999·Current Opinion in Oncology·A J AlbergK J Helzlsouer
Jun 9, 2005·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Kathryn L TerryKarin B Michels
Nov 8, 2008·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Brian L SpragueDiana S M Buist
Sep 10, 2010·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Pierre EngelFrançoise Clavel-Chapelon
Jun 18, 2011·Cancer Prevention Research·Holly R HarrisKarin B Michels
Jun 26, 2004·Breast Cancer Research : BCR·Michelle D Holmes, Walter C Willett
Jan 25, 2008·Annals of Surgical Oncology·I PappoR Ron-El
Jan 6, 2010·Environmental Health Perspectives·Robert A HiattUNKNOWN Breast Cancer and the Environment Research Centers
Mar 19, 2014·Breast Cancer Research : BCR·Ivanesa PardoUNKNOWN Susan G. Komen for the Cure Tissue Bank at the IU Simon Cancer Center
Jul 26, 2014·Human Reproduction·K GuldbrandsenC H Ramlau-Hansen
Jul 1, 2006·Women's Health·Deborah J Clegg, Sue C Heffelfinger
Feb 7, 2016·Gynécologie, obstétrique & fertilité·V GabrieleC Mathelin
Nov 21, 2015·Pediatric Annals·Vivian Y Chang, Tom B Davidson
May 20, 2008·Maturitas·C PichardA Gompel
Aug 15, 2015·Fertility and Sterility·Barbara LukeMaria J Schymura
Aug 3, 2006·Annals of Epidemiology·Chanley M SmallMichele Marcus
Jan 22, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Renée Boynton-JarrettJanet Rich-Edwards
Jun 21, 2006·Gynecological Endocrinology : the Official Journal of the International Society of Gynecological Endocrinology·Herbert Kuhl, John Stevenson
Jun 6, 2015·Journal of Pediatric and Adolescent Gynecology·Ashley M CattranFrank M Biro
Apr 15, 2015·Endocrine-related Cancer·Tim Byers, Rebecca L Sedjo
Jan 6, 2009·American Journal of Obstetrics and Gynecology·Chantal C OrgéasKamila Czene
Apr 26, 2013·The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine·Frank M Biro, Julianna Deardorff
Apr 2, 2014·Fertility and Sterility·Emily S BarrettShanna H Swan
May 2, 2008·American Journal of Epidemiology·Allan JensenSusanne Krüger Kjaer
Dec 28, 1999·Human Reproduction·S D HarlowA J Wilcox
Jun 8, 1999·Human Reproduction·E RicciC La Vecchia
May 11, 2016·European Journal of Cancer Prevention : the Official Journal of the European Cancer Prevention Organisation (ECP)·Takeshi MakiuchiShoichiro Tsugane

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.